Sothema Overview
- Year Founded
-
1976
- Status
-
Public
- Employees
-
1,404
- Stock Symbol
-
SOT
- Investments
-
3
- Share Price
-
$30.71
- (As of Friday Closing)
Sothema General Information
Description
SOTHEMA engages in representation, purchase and sale of pharmaceutical, chemical, health-related, biological, veterinary, plant-based, cosmetic and scented products. The company sells its products in Morocco and overseas.
Contact Information
Website
www.sothema.comCorporate Office
- Z.I. Bouskoura
- Bouskoura, 20180
- Morocco
Corporate Office
- Z.I. Bouskoura
- Bouskoura, 20180
- Morocco
Sothema Stock Performance
As of 20-Nov-2026, Sothema’s stock price is $30.71. Its current market cap is $1.18B with 38.3M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $30.71 | $31.05 | $28.32 - $41.67 | $1.18B | 38.3M | 2.83K | $1.09 |
Sothema Financials Summary
As of 30-Jun-2026, Sothema has a trailing 12-month revenue of $367M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,476,233 | 1,453,720 | 687,828 | 703,774 |
| Revenue | 366,680 | 334,292 | 274,685 | 238,133 |
| EBITDA | 80,619 | 74,037 | 57,736 | 44,299 |
| Net Income | 42,975 | 39,954 | 30,756 | 25,169 |
| Total Assets | 520,963 | 490,413 | 305,539 | 268,951 |
| Total Debt | 86,498 | 103,966 | 56,518 | 49,080 |
Sothema Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sothema Comparisons
Industry
Financing
Details
Sothema Competitors (6)
One of Sothema’s 6 competitors is Caplin Point Laboratories, a Venture Capital-Backed company based in Chennai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Caplin Point Laboratories | Venture Capital-Backed | Chennai, India | ||||
| Sun Pharmaceutical Industries | Corporation | Mumbai, India | ||||
| Celon Labs | Formerly VC-backed | Hyderabad, India | ||||
| Cooper Pharma (Pharmaceuticals) | Corporation | Delhi, India | ||||
| Laprophan | Private Equity-Backed | Casablanca, Morocco |
Sothema Signals
Sothema Investments & Acquisitions (3)
Sothema’s most recent deal was a Merger/Acquisition with Soludia Maghreb for . The deal was made on 17-Dec-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Soludia Maghreb | 17-Dec-2025 | Merger/Acquisition | Pharmaceuticals | ||
| Dislog Group | 09-May-2025 | PE Growth/Expansion | Food Products | ||
| Ziwig | 01-Nov-2022 | Later Stage VC | Laboratory Services (Healthcare) |
Sothema ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Sothema Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Soludia Maghreb | Sale, Morocco | 1998 |
Sothema FAQs
-
When was Sothema founded?
Sothema was founded in 1976.
-
Where is Sothema headquartered?
Sothema is headquartered in Bouskoura, Morocco.
-
What is the size of Sothema?
Sothema has 1,404 total employees.
-
What industry is Sothema in?
Sothema’s primary industry is Pharmaceuticals.
-
Is Sothema a private or public company?
Sothema is a Public company.
-
What is Sothema’s stock symbol?
The ticker symbol for Sothema is SOT.
-
What is the current stock price of Sothema?
As of 20-Nov-2026 the stock price of Sothema is $30.71.
-
What is the current market cap of Sothema?
The current market capitalization of Sothema is $1.18B.
-
What is Sothema’s current revenue?
The trailing twelve month revenue for Sothema is $367M.
-
Who are Sothema’s competitors?
Caplin Point Laboratories, Sun Pharmaceutical Industries, Celon Labs, Cooper Pharma (Pharmaceuticals), and Laprophan are some of the 6 competitors of Sothema.
-
What is Sothema’s annual earnings per share (EPS)?
Sothema’s EPS for 12 months was $1.09.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process